We are a significant global player in the international market for quality generics to fight HIV/ AIDS, TB and malaria.
The oral dosage forms facility at Bangalore is pre-qualified by WHO for manufacture of anti-retroviral drugs (ARVs) and anti TB products and by the US FDA for ARVs under the PEPFAR programme. 7 ARVs are pre-qualified by WHO and 9 have been granted tentative approval by the US FDA.
|
